Drug Profile
MM P01 02
Alternative Names: MM-P01-02Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Myungmoon Pharm
- Class Antibodies; Polyethylene glycols; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for research development in Unspecified in South Korea
- 18 Jan 2016 Research in Undefined indication in South Korea (unspecified route)